Garde Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $373K | Buy |
1,483
+81
| +6% | +$17.4K | 0.02% | 185 |
|
|
2026
Q1 | $305K | Buy |
1,402
+34
| +2% | +$7.54K | 0.02% | 165 |
|
|
2025
Q4 | $313K | Sell |
1,368
-86
| -6% | -$19.6K | 0.02% | 181 |
|
|
2025
Q3 | $337K | Sell |
1,454
-116
| -7% | -$23.6K | 0.02% | 194 |
|
|
2025
Q2 | $291K | Buy |
1,570
+235
| +18% | +$43.7K | 0.02% | 194 |
|
|
2025
Q1 | $280K | Hold |
1,335
| – | – | 0.02% | 191 |
|
|
2024
Q4 | $237K | Buy |
1,335
+200
| +18% | +$36.8K | 0.02% | 200 |
|
|
2024
Q3 | $224K | Hold |
1,135
| – | – | 0.01% | 198 |
|
|
2024
Q2 | $195K | Sell |
1,135
-59
| -5% | -$9.77K | 0.01% | 208 |
|
|
2024
Q1 | $217K | Sell |
1,194
-533
| -31% | -$91.9K | 0.02% | 197 |
|
|
2023
Q4 | $268K | Sell |
1,727
-2,675
| -61% | -$390K | 0.02% | 177 |
|
|
2023
Q3 | $656K | Sell |
4,402
-176
| -4% | -$25.8K | 0.06% | 115 |
|
|
2023
Q2 | $617K | Buy |
+4,578
| New | +$671K | 0.05% | 126 |
|
|
2019
Q3 | – | Sell |
-3,765
| Closed | -$274K | – | 140 |
|
|
2019
Q2 | $274K | Buy |
3,765
+255
| +7% | +$20K | 0.04% | 117 |
|
|
2019
Q1 | $283K | Sell |
3,510
-9,368
| -73% | -$766K | 0.05% | 113 |
|
|
2018
Q4 | $1.19M | Hold |
12,878
| – | – | 0.21% | 60 |
|
|
2018
Q3 | $1.16M | Hold |
12,878
| – | – | 0.2% | 64 |
|
|
2018
Q2 | $1.19M | Sell |
12,878
-831
| -6% | -$81.2K | 0.21% | 61 |
|
|
2018
Q1 | $1.3M | Sell |
13,709
-19
| -0.1% | -$2.09K | 0.24% | 53 |
|
|
2017
Q4 | $1.33M | Sell |
13,728
-131
| -0.9% | -$12.3K | 0.25% | 51 |
|
|
2017
Q3 | $1.23M | Buy |
13,859
+9,383
| +210% | +$714K | 0.24% | 54 |
|
|
2017
Q2 | $325K | Buy |
+4,476
| New | +$301K | 0.08% | 93 |
|
|
2016
Q4 | – | Sell |
-10,211
| Closed | -$556K | – | 117 |
|
|
2016
Q3 | $556K | Buy |
+10,211
| New | +$661K | 0.18% | 95 |
|
|
2015
Q4 | – | Sell |
-10,211
| Closed | -$556K | – | 109 |
|
|
2015
Q3 | $556K | Hold |
10,211
| – | – | 0.18% | 95 |
|
|
2015
Q2 | $686K | Sell |
10,211
-148
| -1% | -$9.66K | 0.21% | 85 |
|
|
2015
Q1 | $606K | Buy |
10,359
+895
| +9% | +$54.1K | 0.18% | 90 |
|
|
2014
Q4 | $619K | Buy |
+9,464
| New | +$597K | 0.19% | 89 |
|
Other funds holding ABBV
Garde Capital's ABBV Position: Q2 2026 in Review
Garde Capital increased its AbbVie (ABBV) stake by 5.8% in Q2 2026, buying an estimated $17.4K and bringing the position to 1,483 shares worth $373K. The position accounts for 0.02% of the portfolio, ranked #185.
Garde Capital first reported a position in ABBV in Q4 2014 and has held it in 27 quarters since. The position peaked at $1.33M in Q4 2017. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Garde Capital held 1,483 shares of AbbVie worth $373K as of Q2 2026.
- Garde Capital bought 81 AbbVie shares in Q2 2026, an estimated $17.4K.
- AbbVie made up 0.02% of Garde Capital's portfolio in Q2 2026, its #185 holding.
- Garde Capital first reported a position in AbbVie in Q4 2014 and has held it in 27 quarters since.
- Garde Capital's AbbVie position peaked at $1.33M in Q4 2017.
- 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Garde Capital's 13F filing for Q2 2026, filed 31 Jul 2026.